Scientists probe Brain's 'Alertness' chemical in older insomniacs to fight dementia
NCT ID NCT06694441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a brain chemical called norepinephrine affects sleep and thinking in older adults with insomnia, who are at higher risk for Alzheimer's. Researchers will measure this chemical in the blood and use a light therapy to try to improve sleep and mental sharpness. The goal is to understand the link between poor sleep, brain chemistry, and memory decline.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University Feinberg School of Medicine, Center for Circadian and Sleep Medicine
RECRUITINGChicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light therapy during sleep may offer a Drug-Free path to better rest
- Mind over bladder: can sleep training curb nighttime urges?
- Can an ancient herbal formula unlock better sleep and weight loss?
- Could a simple sleep guide ease insomnia in lung disease?
- Digital sleep coaching for seniors: a new hope for insomnia?
- Fixing sleep, fortifying hearts: a new trial tests the link